Patents by Inventor Michael Willis
Michael Willis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20060005598Abstract: A system for monitoring and controlling a tube milling operation generally includes a weld box, a roll, a first sensor, and a controller. The roll is disposed within the weld box for simultaneously compressing and guiding a stock material. The first sensor detects either an actual load applied to the roll by the stock material or a position of the roll. The controller is in data communication with the first sensor and is operable to displace the roll along a first axis relative to the weld box in accordance with a difference between either the actual load and a load parameter or the roll position and a position parameter.Type: ApplicationFiled: July 6, 2004Publication date: January 12, 2006Inventor: Michael Willis
-
Publication number: 20050257308Abstract: A novelty article or article of wearing apparel is provided having an exposed surface that is covered by contiguous distinct zones of at least two contrasting colors. These contiguous distinct zones are arranged to define a camouflage pattern. The colors used in the article are colors that do not blend with environmental colors and are selected to correspond to colors adopted by a group, such as a team or school, for which the user of the article has an affinity or affiliation. In specific embodiments, the colors correspond to the team colors of a professional or amateur sports team. In further specific embodiments, the novelty article may additionally include a logo or symbol of the team.Type: ApplicationFiled: May 19, 2004Publication date: November 24, 2005Inventor: Michael Willis
-
Patent number: 6962784Abstract: This invention discloses a method for preparing a complex comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further discloses Complexes comprising one or more VEGF Nucleic Acid Ligands in association with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further includes a Lipid construct comprising a VEGF Nucleic Acid Ligand or Complex and methods for making the same.Type: GrantFiled: July 25, 2002Date of Patent: November 8, 2005Assignee: Gilead Sciences, Inc.Inventors: Nebojsa Janjic, Larry Gold, Paul Schmidt, Chandra Vargeese, Michael Willis
-
Publication number: 20050198387Abstract: A method and system for associating a process on a multi-user device with a host address unique to a user session associated with the process begins by allocating a unique host address for the user session and assigning it to a network adapter. Requests that may bind network resources are intercepted, and relevant bind request parameters are manipulated to specify the host address associated with the user session. The original target of the request is invoked with potentially modified parameters.Type: ApplicationFiled: December 18, 2004Publication date: September 8, 2005Inventor: Michael Willis
-
Publication number: 20040192632Abstract: This invention discloses a method for preparing a complex comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further discloses Complexes comprising one or more VEGF Nucleic Acid Ligands in association with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further includes a Lipid construct comprising a VEGF Nucleic Acid Ligand or Complex and methods for making the same.Type: ApplicationFiled: April 26, 2004Publication date: September 30, 2004Applicant: Gilead Sciences, Inc.Inventors: Nebojsa Janjic, Larry Gold, Paul Schmidt, Chandra Vargeese, Michael Willis
-
Publication number: 20040132067Abstract: A method for identifying nucleic acid ligands to target molecules using the SELEX procedure wherein the candidate nucleic acids contain photoreactive groups and nucleic acid ligands identified thereby are claimed. The complexes of increased affinity nucleic acids and target molecules formed in the procedure are crosslinked by irradiation to facilitate separation from unbound nucleic acids. In other methods partitioning of high and low affinity nucleic acids is facilitated by primer extension steps as shown in the figure in which chain termination nucleotides, digestion resistant nucleotides or nucleotides that allow retention of the cDNA product on an affinity matrix are differentially incorporated into the cDNA products of either the high or low affinity nucleic acids and the cDNA products are treated accordingly to amplification, enzymatic or chemical digestion or by contact with an affinity matrix.Type: ApplicationFiled: October 8, 2003Publication date: July 8, 2004Applicant: SOMALOGIC, INC.Inventors: Larry Gold, Michael Willis, Tad Koch, Steven Ringquist, Kirk Jensen, Brent Atkinson
-
Patent number: 6610903Abstract: There is provided a fluid management material for personal care products which distributes artificial menses according to the gush/distribution test taught herein such that it has a distribution ratio of at least about 0.06. Its preferred that the fluid management material be part of an absorbent materials system having a first fibrous layer, a middle layer adjacent the first layer having hydrophilic oriented surface fibers, and a second fibrous layer adjacent the middle layer. In a personal care product configuration the oriented surface fibers result in a distribution ratio of at least 0.06 where the distribution ratio is a ratio of average of the mass of two end zones of a product divided by the mass of the center zone.Type: GrantFiled: November 4, 1999Date of Patent: August 26, 2003Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Margaret Gwyn Latimer, Gregory Marc Lefkowitz, David Michael Matela, Jeffrey Michael Willis
-
Publication number: 20030114404Abstract: This invention discloses a method for preparing a complex comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further discloses Complexes comprising one or more VEGF Nucleic Acid Ligands in association with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further includes a Lipid construct comprising a VEGF Nucleic Acid Ligand or Complex and methods for making the same.Type: ApplicationFiled: July 25, 2002Publication date: June 19, 2003Applicant: Gilead Sciences, Inc.Inventors: Nebojsa Janjic, Larry Gold, Paul Schmidt, Chandra Vargeese, Michael Willis
-
Patent number: 6482594Abstract: Methods to obtain nucleic acid ligands that photocrosslink to target molecules associated with a disease state are provided. The methods presented are variations on the photoSELEX methods for obtaining nucleic acid ligands. In one method, a candidate mixture of photocrosslinkable nucleic acids is contacted with a biological substance obtained from a source associated with a disease state suspected of containing a target molecule to form nucleic acid-target molecule complexes, the complexes are irradiated to form crosslinked complexes, the photocrosslinked complexes are partitioned from the remainder of the candidate mixture; and the nucleic acid ligands that photocrosslink to molecule are retained. These nucleic acids are then contacted with a second biological substance of the same type as the first, but obtained from a source not associated with a disease state. This removes nucleic acids with affinity to molecules that are not associated with the disease state.Type: GrantFiled: June 14, 2001Date of Patent: November 19, 2002Assignee: SomaLogic, Inc.Inventors: Larry Gold, Michael Willis, Tad Koch, Steven Ringquist, Kirk Jensen, Brent Atkinson
-
Patent number: 6461433Abstract: A method and apparatus for precisely applying radioactive material to a substrate such as a brachytherapy device is disclosed. A radioactive fluid adapted to cure rapidly is deposited as discrete dots onto a surface with a fluid-jet printhead. The apparatus comprises a fluid-jet printhead in communication with a chamber containing radioactive fluid to be applied by the printhead. The printhead is microprocessor driven, and the microprocessor may be provided with feedback from a station where the radioactivity deposited on a preceding substrate in a batch is measured, permitting the system to be recalibrated on an ongoing basis as the batch of printed devices is produced. Compensation for attenuation of radiation by a casing may also be made part of the feedback technique. Also disclosed is a brachytherapy device having printed on a surface dots of radiation-emitting material, in a pattern comprising various bands, dots or areas.Type: GrantFiled: July 5, 2000Date of Patent: October 8, 2002Assignee: International Brachytherapy, S.A.Inventors: John L. Carden, Jr., John L. Russell, Jr., James Edward Fox, Alan Lionel Hudd, Michael Willis
-
Publication number: 20020106652Abstract: A method for identifying nucleic acid ligands to target molecules using the SELEX procedure. Nucleic acid candidate sequences contain photoreactive groups. After exposure of the nucleic acid sequences to the target molecule, nucleic acid-target molecule complexes are formed between nucleic acids having increased affinity to the target molecule and the target molecule. The complexes are irradiated such that photocrosslinks form between the photoreactive groups of the bound nucleic acids and the target molecule. The photocrosslinked complexes are separated from unbound nucleic acids, and the nucleic acids amplified to yield a ligand-enriched mixture of nucleic acids.Type: ApplicationFiled: June 14, 2001Publication date: August 8, 2002Applicant: SomaLogic, Inc.Inventors: Larry Gold, Michael Willis, Tad Koch, Steven Ringquist, Kirk Jensen, Brent Atkinson
-
Patent number: 6426335Abstract: This invention discloses a method for preparing a complex comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further discloses Complexes comprising one or more VEGF Nucleic Acid Ligands in association with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further includes a Lipid construct comprising a VEGF Nucleic Acid Ligand or Complex and methods for making the same.Type: GrantFiled: March 13, 2000Date of Patent: July 30, 2002Assignee: Gilead Sciences, Inc.Inventors: Nebojsa Janjic, Larry Gold, Paul Schmidt, Chandra Vargeese, Michael Willis
-
Patent number: 6291184Abstract: A method for identifying nucleic acid ligands to target molecules using the SELEX procedure wherein the candidate nucleic acids contain photoreactive groups and nucleic acid ligands identified thereby are claimed. The complexes of increased affinity nucleic acids and target molecules formed in the procedure are crosslinked by irradiation to facilitate separation from unbound nucleic acids. In other methods partitioning of high and low affinity nucleic acids is facilitated by primer extension steps as shown in the figure in which chain termination nucleotides, digestion resistant nucleotides or nucleotides that allow retention of the cDNA product on an affinity matrix are differentially incorporated into the cDNA products of either the high or low affinity nucleic acids and the cDNA products are treated accordingly to amplification, enzymatic or chemical digestion or by contact with an affinity matrix.Type: GrantFiled: December 13, 1999Date of Patent: September 18, 2001Assignee: SomaLogic, Inc.Inventors: Larry Gold, Michael Willis, Tad Koch, Steven Ringquist, Kirk Jensen, Brent Atkinson
-
Patent number: 6086942Abstract: A method and apparatus for precisely applying radioactive material to a substrate such as a brachytherapy device is disclosed. A radioactive fluid adapted to cure rapidly is deposited as discrete dots onto a surface with a fluid-jet printhead. The apparatus comprises a fluid-jet printhead in communication with a chamber containing radioactive fluid to be applied by the printhead. The printhead is microprocessor driven, and the microprocessor may be provided with feedback from a station where the radioactivity deposited on a preceding substrate in a batch is measured, permitting the system to be recalibrated on an ongoing basis as the batch of printed devices is produced. Compensation for attenuation of radiation by a casing may also be made part of the feedback technique. Also disclosed is a brachytherapy device having printed on a surface dots of radiation-emitting material, in a pattern comprising various bands, dots or areas.Type: GrantFiled: May 27, 1998Date of Patent: July 11, 2000Assignee: International Brachytherapy s.a.Inventors: John L. Carden, Jr., John L. Russell, Jr., James Edward Fox, Alan Lionel Hudd, Michael Willis
-
Patent number: 6033516Abstract: In the production of an anticopy film serving for covering documents against copying, opaque, strip-like coverings are applied by printing to the individual layers of a transparent, multilayer film in a mutually offset arrangement in such a way that the film appears opaque in the plan view, but transparent in an inclined viewing direction. To this end, a film web is printed with the coverings in sections corresponding to the layers, and the sections are subsequently folded over to give the layers.Type: GrantFiled: July 14, 1994Date of Patent: March 7, 2000Assignee: Emtec Magnetics GmbHInventors: Helmut Steininger, Peter Heilmann, Michael Willis
-
Patent number: 6001577Abstract: A method for identifying nucleic acid ligands to target molecules using the SELEX procedure wherein the candidate nucleic acids contain photoreactive groups and nucleic acid ligands identified thereby are claimed. The complexes of increased affinity nucleic acids and target molecules formed in the procedure are crosslinked by irradiation to facilitate separation from unbound nucleic acids. In other methods partitioning of high and low affinity nucleic acids is facilitated by primer extension steps as shown in the figure in which chain termination nucleotides, digestion resistant nucleotides or nucleotides that allow retention of the cDNA product on an affinity matrix arc differentially incorporated into the cDNA products of either the high or low affinity nucleic acids and the cDNA products are treated accordingly to amplification, enzymatic or chemical digestion or by contact with an affinity matrix.Type: GrantFiled: June 8, 1998Date of Patent: December 14, 1999Assignee: NeXstar Pharmaceuticals, Inc.Inventors: Larry Gold, Michael Willis, Tad Koch, Steven Ringquist, Kirk Jensen, Brent Atkinson
-
Patent number: 5763177Abstract: A method for identifying nucleic acid ligands to target molecules using the SELEX pocedure wherein the candidate nucleic acids contain photoreactive groups and nucleic acid ligands identified thereby are claimed. The complexes of increased affinity nucleic acids and target molecules formed in the procedure are crosslinked by irradiation to facilitate separation from unbound nucleic acids. In other methods partioning of high and low affinity nucleic acids is facilitated by primer extension steps as shown in the figure in which chain termination nucleotides, digestion resistant nucleotides or nucleotides that allow retention of the cDNA product on an affinity matrix are differentially incorporated into the cDNA products of either the high or low affinity nucleic acids and the cDNA products are treated accordingly to amplification, enzymatic or chemical digestion or by contact with an affinity matrix.Type: GrantFiled: March 8, 1996Date of Patent: June 9, 1998Assignee: NeXstar Pharmaceuticals, Inc.Inventors: Larry Gold, Michael Willis, Tad Koch, Steven Ringquist, Kirk Jensen, Brent Atkinson
-
Patent number: 4886349Abstract: This disclosure is directed to a temples-less eyeglass frame having a central nose bridge portion, left and right lens frame portions, a left wing portion substantially perpendicular to the left lens frame portion, a right wing portion substantially perpendicular to the right lens frame portion, and left and right resilient foam temple bearing members attached to the inner end surfaces of the left and right wing portions, so as to rest in and exert pressure on both temple area only of the wearer when in use. Although the left and right wing portions can be integral with the left and right lens frame portions, this is not necessary. The left and right wing portions can be hingedly connected to the left and right lens frame portions, respectively, with or without spring-biasing to move the left and right wing portions inwardly when not being worn.Type: GrantFiled: November 27, 1987Date of Patent: December 12, 1989Assignee: Michael AllenInventor: Michael A. Willis
-
Patent number: D279851Type: GrantFiled: October 14, 1980Date of Patent: July 30, 1985Inventor: Michael A. Willis
-
Patent number: D320740Type: GrantFiled: April 27, 1989Date of Patent: October 15, 1991Assignee: Imperial Chemical Industries plcInventors: Michael Willis, David Fielding